SE399706B - Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln - Google Patents

Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln

Info

Publication number
SE399706B
SE399706B SE7209266A SE926672A SE399706B SE 399706 B SE399706 B SE 399706B SE 7209266 A SE7209266 A SE 7209266A SE 926672 A SE926672 A SE 926672A SE 399706 B SE399706 B SE 399706B
Authority
SE
Sweden
Prior art keywords
ostrus
contractive
pregnancy
termination
regulation
Prior art date
Application number
SE7209266A
Other languages
English (en)
Swedish (sv)
Inventor
K B Mallion
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE399706B publication Critical patent/SE399706B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7209266A 1971-07-14 1972-07-13 Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln SE399706B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3304971 1971-07-14
GB3304971A GB1372541A (en) 1971-07-14 1971-12-16 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
SE399706B true SE399706B (sv) 1978-02-27

Family

ID=26261688

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7209266A SE399706B (sv) 1971-07-14 1972-07-13 Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln
SE7504707A SE7504707L (de) 1971-07-14 1975-04-23

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7504707A SE7504707L (de) 1971-07-14 1975-04-23

Country Status (12)

Country Link
JP (1) JPS5629665B1 (de)
BE (1) BE786251A (de)
CA (1) CA986926A (de)
CH (1) CH575902A5 (de)
DD (1) DD102141A5 (de)
DE (1) DE2234709C2 (de)
FR (1) FR2145697B1 (de)
GB (1) GB1372541A (de)
HU (1) HU166719B (de)
IE (1) IE36914B1 (de)
NL (1) NL7209817A (de)
SE (2) SE399706B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143051A (en) 1972-07-13 1979-03-06 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
FR2361410A1 (fr) * 1972-07-13 1978-03-10 Pfizer Alkylphosphonates de dialkyle, utiles comme intermediaires de synthese de prostaglandines
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
ES2213504T1 (es) * 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HU212570B (en) * 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
AU2003270693A1 (en) * 2002-09-19 2004-04-08 Ilex Oncology Research, Sarl Substituted ketophosphonate compounds having bone anabolic activity
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative

Also Published As

Publication number Publication date
IE36914L (en) 1973-01-14
HU166719B (de) 1975-05-28
BE786251A (fr) 1973-01-15
IE36914B1 (en) 1977-03-30
SE7504707L (de) 1975-04-23
NL7209817A (de) 1973-01-16
JPS5629665B1 (de) 1981-07-09
DE2234709C2 (de) 1982-06-03
FR2145697A1 (de) 1973-02-23
DD102141A5 (de) 1973-12-05
CA986926A (en) 1976-04-06
AU4394072A (en) 1974-01-03
DE2234709A1 (de) 1973-02-01
GB1372541A (en) 1974-10-30
FR2145697B1 (de) 1976-04-16
CH575902A5 (de) 1976-05-31

Similar Documents

Publication Publication Date Title
SE390414B (sv) 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE403286B (sv) Mellanprodukter for framstellning av 1,4-hydroximorfinanderivat
SE414304B (sv) Estrar av cyklopropankarboxylsyraderivat for pesticidiskt bruk
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE435289B (sv) O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE399706B (sv) Prostansyraderivat till anvendning som kontraceptiva medel, for avbrytande av havandeskap och for reglering av ostruscykeln
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE382809B (sv) Forfarande for framstellning av fenoxiettiksyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK136612C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-4-pregnen-21-syrederivater
SE410458B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE7613500L (sv) Forfarande for framstellning av cefemderivat
NO137597C (no) Xantonderivater for bruk som mellomprodukter ved fremstilling av terapeutisk virksomme forbindelser
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE430057B (sv) Mellanprodukt till anvendning for framstellning av 4-amino-3,5-dihalogenfenyletanolaminer
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat
SE418964B (sv) Piperidinyloxiderivat avsedda som mellanprodukter for framstellning av piperidinoalkylfenotiaziner
SE389101B (sv) Forfarande for framstellning av fenylettiksyraderivat
SE386668B (sv) Forfarande for framstellning av tiodipropionsyraderivat
SE7409092L (sv) Nytt forfarande for framstellning av 2-iminotiazolidinderivat.
SE408897B (sv) Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider